APHY: Assured Pharmacy’s Reason for Being Explains Success
Assured Pharmacy – APHY – Stock Guru Profile
CHRONIC PAIN – Undeserved Expanding Market
Robert DelVecchio spoke with Stock Guru recently. “I am immensely pleased to see the issue of chronic pain get the attention it so richly deserves. This is an expanding problem in our country. The Newsweek cover article represents what I hope will be the beginning of a real discussion of this very real issue in our society. The article clearly indicates that insurers are glad to pay for opioids for pain medication. These are the narcotics that block messages in the brain and make patients care less about their pain. Actually, there are 200 million opioid prescriptions written in America each year and that’s our market.
“We have procedures in place that streamline the verification of prescriptions and because a high percentage of our patients return each month. With our protocols and extensive networked relationships we are able to determine which prescriptions are legitimate rather quickly. This reduces the patient’s wait time. If we have an ongoing and continuing relationship with the patient we can fill the prescription with confidence. If we do not have that type of relationship we have protocol for verifying the prescription that often circumvents the waiting time a patient might experience with a regular pharmacy. AND KEEP IN MIND all the while this is a patient in chronic pain and delays are crucial for the patient and their families. Often you see patients that may have doubled up on pain medication during an extremely bad time during their ONE MONTH of medication and they are truly in dire need. The time it takes to confirm a prescription is especially crucial for these patients.”
Robert DelVecchio continued, “I think the example that Newsweek used of a young man named Bono, who is 28 years old and born with a tumor on his spine who has spent his whole life in pain is a perfect example. At one point this young man was on so much OxyContin that “the dosages would have killed someone else,” said his mother, Kadie Dempsey. This young man said: “I went to about 20 different pharmacies,and they told me, ‘We don’t treat drug addicts here’.”
“That will never happen at our pharmacy and it is this very understanding of this market and its unique challenges that has produced the results you see in our financials and why we project tremendous growth. It is our understanding of this market and business protocols and projects which explain precisely why we have experienced a 20% average quarterly revenue growth for six consecutive quarters.”
This company DOES NOT compete with Wal-Mart! This company fills a void in patient and physician pharmacy needs! Their success is reflected in expanding sales!
Stay tuned to understand why specialized pharmacies appeal to physicians who treat patients with chronic pain.
Source: APHY
Assured Pharmacy
17935 Sky Park Circle, Ste. F
Irvine, CA 92614
Phone: (949) 222-9971
Fax: (949) 222-0978
Investor Relations:
Andrew Brown
ROI Group LLC
212-495-0202
abrown@roiny.com
About Assured Pharmacy: Assured Pharmacy provides customized services for patients with and physicians treating chronic pain, including specialized expertise in dispensing pain medication, including Class II substances, streamlined prescription processes, digital prescribing technologies, and specialty drug compounding services. APHY also offers a complete line of durable medical equipment through its DME division. APHY currently operates retail sites in Portland, Oregon (three), Santa Ana and Riverside, California, and Kirkland, Washington. More information about APHY is available at http://www.assuredpharmacy.com.
Forward Looking Statements: Certain statements in this news release may constitute “forward-looking” statements within the meaning of section 21E of the Securities and Exchange Act of 1934. The Company believes that its expectations, as expressed in these statements are based on reasonable assumptions regarding the risks and uncertainties inherent in achieving those expectations. These statements are not, however, guarantees of future performance and actual results may differ materially. Some of the factors that may affect the forward looking statements in this news release are the availability of licensed personnel to operate pharmacies, the availability of suitable pharmacy locations, and the acceptance of new technologies by the medical profession. Other risk factors are listed in the most recent Annual Report on Form 10-KSB, Quarterly Report on Form 10-QSB, and most recent Registration Statement on Form SB-2 filed with the Securities and Exchange Commission. Such forward-looking statements involve risks, uncertainties, which may cause the actual results, performance, or achievement expressed or implied to differ.
StockGuru.com is owned and operated by Pentony Enterprises LLC, 9555 Lebanon Road, Suite 103, Frisco, Texas 75035. Telephone: (469) 252-3030. Web: StockGuru.com. Email: Publisher@stockguru.com.
Disclosure: Pentony Enterprises LLC has been compensated $10,000 directly from the company for profile coverage. Pentony Enterprises is not a registered investment adviser or a broker/dealer. Pentony Enterprises LLC makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person, or that an investment in such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk.